$SINT
Sintx Technologies, Inc. Stock $sint

$sint Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222022235 Filed on August 12, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$426.0K	$240.0K	$129.0K
YoY Change	78.24%	137.62%	29.0%
Cost Of Revenue	$89.00K	$66.00K	$80.00K
YoY Change	-53.16%	-9.59%	33.33%
Gross Profit	$337.0K	$174.0K	$49.00K
YoY Change	587.76%	521.43%	22.5%
Gross Profit Margin	79.11%	72.5%	37.98%
Selling, General & Admin	$1.360M	$1.331M	$1.250M
YoY Change	7.0%	12.13%	-3.1%
% of Gross Profit	403.56%	764.94%	2551.02%
Research & Development	$1.523M	$1.476M	$1.653M
YoY Change	-4.99%	22.59%	3.31%
% of Gross Profit	451.93%	848.28%	3373.47%
Depreciation & Amortization	$101.0K	$71.00K	$69.00K
YoY Change	102.0%	69.05%	130.0%
% of Gross Profit	29.97%	40.8%	140.82%
Operating Expenses	$3.130M	$2.957M	$2.929M
YoY Change	8.91%	23.67%	1.7%
Operating Profit	-$2.793M	-$2.783M	-$2.880M
YoY Change	-1.13%	17.77%	1.41%
Interest Expense	$61.00K	$110.0K	$35.00K
YoY Change	-87.37%	223.53%	-117.5%
% of Operating Profit
Other Income/Expense, Net	$69.00K	$271.0K
YoY Change	-7000.0%	65.24%
Pretax Income	-$2.724M	-$2.512M	-$2.845M
YoY Change	16.26%	14.23%	8.17%
Income Tax
% Of Pretax Income
Net Earnings	-$2.724M	-$2.512M	-$2.845M
YoY Change	16.26%	14.23%	8.05%
Net Earnings / Revenue	-639.44%	-1046.67%	-2205.43%
Basic Earnings Per Share	-$0.11	-$0.10
Diluted Earnings Per Share	-$0.11	-$0.10	-$115.1K
COMMON SHARES
Basic Shares Outstanding	24.72M shares	24.72M shares	247.1K shares
Diluted Shares Outstanding	25.09M shares	25.08M shares	247.1K shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.779M	$7.747M	$10.86M
YoY Change	-72.19%	-65.06%	-53.72%
Cash & Equivalents	$4.779M	$7.747M	$10.86M
Short-Term Investments
Other Short-Term Assets	$46.00K	$105.0K	$721.0K
YoY Change	-87.96%	-83.87%	-9.88%
Inventory	$749.0K	$775.0K	$299.0K
Prepaid Expenses
Receivables	$230.0K	$268.0K	$106.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.048M	$9.228M	$11.99M
YoY Change	-66.67%	-60.24%	-53.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.493M	$5.085M	$6.440M
YoY Change	-13.18%	85.72%	162.86%
Goodwill
YoY Change
Intangibles	$27.00K	$29.00K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$81.00K	$80.00K	$424.0K
YoY Change	-77.62%	-81.61%	-3.64%
Total Long-Term Assets	$8.515M	$8.266M	$6.894M
YoY Change	26.67%	157.75%	135.29%
TOTAL ASSETS
Total Short-Term Assets	$6.048M	$9.228M	$11.99M
Total Long-Term Assets	$8.515M	$8.266M	$6.894M
Total Assets	$14.56M	$17.49M	$18.88M
YoY Change	-41.44%	-33.77%	-34.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$289.0K	$372.0K	$490.0K
YoY Change	71.01%	141.56%	22.5%
Accrued Expenses	$1.554M	$1.552M	$1.346M
YoY Change	-25.4%	-8.27%	-10.27%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$524.0K
YoY Change
Long-Term Debt Due	$168.0K	$148.0K
YoY Change	184.75%	428.57%
Total Short-Term Liabilities	$2.872M	$2.977M	$2.669M
YoY Change	-8.91%	-6.85%	-16.85%
LONG-TERM LIABILITIES
Long-Term Debt	$393.0K	$393.0K	$0.00
YoY Change	-12.67%	-18.46%	-100.0%
Other Long-Term Liabilities	$1.811M	$1.968M	$1.763M
YoY Change	-10.57%	56.31%	28.69%
Total Long-Term Liabilities	$393.0K	$393.0K	$1.763M
YoY Change	-84.12%	-77.43%	-6.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.872M	$2.977M	$2.669M
Total Long-Term Liabilities	$393.0K	$393.0K	$1.763M
Total Liabilities	$5.148M	$5.445M	$4.432M
YoY Change	-8.53%	10.29%	-12.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$258.5M	-$255.8M
YoY Change
Common Stock	$247.0K	$247.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.415M	$12.05M	$14.45M
YoY Change
Total Liabilities & Shareholders Equity	$14.56M	$17.49M	$18.88M
YoY Change	-41.44%	-33.77%	-34.18%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.724M	-$2.512M	-$2.845M
YoY Change	16.26%	14.23%	8.05%
Depreciation, Depletion And Amortization	$101.0K	$71.00K	$69.00K
YoY Change	102.0%	69.05%	130.0%
Cash From Operating Activities	-$2.458M	-$2.542M	-$3.180M
YoY Change	2.08%	8.22%	6.35%
INVESTING ACTIVITIES
Capital Expenditures	-$511.0K	-$368.0K	-$230.0K
YoY Change	-80.22%	-15.6%	21.05%
Acquisitions
YoY Change
Other Investing Activities	$1.000K	$303.0K	$0.00
YoY Change		-79.64%	-100.0%
Cash From Investing Activities	-$510.0K	-$65.00K	-$230.0K
YoY Change	-80.26%	-106.18%	-156.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	-509.0K
YoY Change		5555.56%
NET CHANGE
Cash From Operating Activities	-2.458M	-2.542M	-3.180M
Cash From Investing Activities	-510.0K	-65.00K	-230.0K
Cash From Financing Activities	0.000	-509.0K
Net Change In Cash	-2.968M	-3.116M	$0.00
YoY Change	-40.54%	138.59%	-100.0%
FREE CASH FLOW
Cash From Operating Activities	-$2.458M	-$2.542M	-$3.180M
Capital Expenditures	-$511.0K	-$368.0K	-$230.0K
Free Cash Flow	-$1.947M	-$2.174M	-$2.950M
YoY Change	-1206.25%	13.64%	5.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001269026
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q2	SINT	Grant Expenses GrantExpenses		usd
	SINT	Grant Expenses GrantExpenses		usd
CY2022Q2	us-gaap	Interest Expense Other InterestExpenseOther		usd
CY2021Q1	SINT	Stock Issued During Period Value Issuance Of Common Stock From Cashless Exercise Of Warrants StockIssuedDuringPeriodValueIssuanceOfCommonStockFromCashlessExerciseOfWarrants		usd
	us-gaap	Other Noncash Income OtherNoncashIncome		usd
	SINT	Forgivenessof Paycheck Protection Programe Loan ForgivenessofPaycheckProtectionProgrameLoan		usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities		usd
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable		usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
	SINT	Proceeds From Sale Of Property And Equipment ProceedsFromSaleOfPropertyAndEquipment		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
	SINT	Extinguishment Of Derivative Liabilities Through Exercise Of Warrants ExtinguishmentOfDerivativeLiabilitiesThroughExerciseOfWarrants		usd
	SINT	Acquisition Of Subsidiary Through Assumption Of Debt AcquisitionOfSubsidiaryThroughAssumptionOfDebt		usd
	SINT	Reduction Of Debt Through Increase In Accrued Liabilities ReductionOfDebtThroughIncreaseInAccruedLiabilities		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2022Q2	SINT	Deemed Dividend And Accretion Of Discounts Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountsEffectOfDilutiveWarrantSecurities		usd
CY2022Q2	SINT	Deemed Dividend And Accretion Of Discount Diluted Calculation DeemedDividendAndAccretionOfDiscountDilutedCalculation		usd
CY2022Q2	SINT	Net Income Effect Of Dilutive Warrant Securities Per Share NetIncomeEffectOfDilutiveWarrantSecuritiesPerShare
CY2022Q2	SINT	Basic Deemed Dividend And Accretion Of Discount Basic Calculation BasicDeemedDividendAndAccretionOfDiscountBasicCalculation
CY2022Q2	SINT	Deemed Dividend And Accretion Of Discount Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountEffectOfDilutiveWarrantSecurities
CY2022Q2	SINT	Dilutive Deemed Dividend And Accretion Of Discount Diluted Calculation DilutiveDeemedDividendAndAccretionOfDiscountDilutedCalculation
CY2022Q2	SINT	Net Loss Attributable To Common Stockholders Effect Of Dilutive Warrant Securities NetLossAttributableToCommonStockholdersEffectOfDilutiveWarrantSecurities
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
	SINT	Deemed Dividend And Accretion Of Discounts Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountsEffectOfDilutiveWarrantSecurities		usd
	SINT	Deemed Dividend And Accretion Of Discount Diluted Calculation DeemedDividendAndAccretionOfDiscountDilutedCalculation		usd
	SINT	Net Income Effect Of Dilutive Warrant Securities Per Share NetIncomeEffectOfDilutiveWarrantSecuritiesPerShare
	SINT	Basic Deemed Dividend And Accretion Of Discount Basic Calculation BasicDeemedDividendAndAccretionOfDiscountBasicCalculation
	SINT	Deemed Dividend And Accretion Of Discount Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountEffectOfDilutiveWarrantSecurities
	SINT	Dilutive Deemed Dividend And Accretion Of Discount Diluted Calculation DilutiveDeemedDividendAndAccretionOfDiscountDilutedCalculation
	SINT	Net Loss Attributable To Common Stockholders Effect Of Dilutive Warrant Securities NetLossAttributableToCommonStockholdersEffectOfDilutiveWarrantSecurities
CY2021Q2	SINT	Net Income Effect Of Dilutive Warrant Securities NetIncomeEffectOfDilutiveWarrantSecurities		usd
CY2021Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
CY2021Q2	SINT	Deemed Dividend And Accretion Of Discounts Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountsEffectOfDilutiveWarrantSecurities		usd
CY2021Q2	SINT	Deemed Dividend And Accretion Of Discount Diluted Calculation DeemedDividendAndAccretionOfDiscountDilutedCalculation		usd
CY2021Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther		usd
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2021Q2	SINT	Net Income Effect Of Dilutive Warrant Securities Per Share NetIncomeEffectOfDilutiveWarrantSecuritiesPerShare
CY2021Q2	SINT	Basic Deemed Dividend And Accretion Of Discount Basic Calculation BasicDeemedDividendAndAccretionOfDiscountBasicCalculation
CY2021Q2	SINT	Deemed Dividend And Accretion Of Discount Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountEffectOfDilutiveWarrantSecurities
CY2021Q2	SINT	Dilutive Deemed Dividend And Accretion Of Discount Diluted Calculation DilutiveDeemedDividendAndAccretionOfDiscountDilutedCalculation
CY2021Q2	SINT	Net Loss Attributable To Common Stockholders Effect Of Dilutive Warrant Securities NetLossAttributableToCommonStockholdersEffectOfDilutiveWarrantSecurities
	SINT	Net Income Effect Of Dilutive Warrant Securities NetIncomeEffectOfDilutiveWarrantSecurities		usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		usd
	SINT	Deemed Dividend And Accretion Of Discounts Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountsEffectOfDilutiveWarrantSecurities		usd
	SINT	Deemed Dividend And Accretion Of Discount Diluted Calculation DeemedDividendAndAccretionOfDiscountDilutedCalculation		usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther		usd
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
	SINT	Net Income Effect Of Dilutive Warrant Securities Per Share NetIncomeEffectOfDilutiveWarrantSecuritiesPerShare
	SINT	Basic Deemed Dividend And Accretion Of Discount Basic Calculation BasicDeemedDividendAndAccretionOfDiscountBasicCalculation
	SINT	Deemed Dividend And Accretion Of Discount Effect Of Dilutive Warrant Securities DeemedDividendAndAccretionOfDiscountEffectOfDilutiveWarrantSecurities
	SINT	Dilutive Deemed Dividend And Accretion Of Discount Diluted Calculation DilutiveDeemedDividendAndAccretionOfDiscountDilutedCalculation
	SINT	Net Loss Attributable To Common Stockholders Effect Of Dilutive Warrant Securities NetLossAttributableToCommonStockholdersEffectOfDilutiveWarrantSecurities
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24723856	shares
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33624
	dei	Entity Registrant Name EntityRegistrantName	SINTX Technologies, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1375299
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1885 West 2100 South
	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84119
	dei	City Area Code CityAreaCode	(801)
	dei	Local Phone Number LocalPhoneNumber	839-3500
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	SINT
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7747000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14273000	usd
CY2022Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	268000	usd
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	102000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	762000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	350000	usd
CY2022Q2	us-gaap	Inventory Gross InventoryGross	346000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	303000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	105000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	9228000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	15028000	usd
CY2022Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	429000	usd
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	294000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5085000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4025000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	31000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2643000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2385000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	80000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	77000	usd
CY2022Q2	us-gaap	Assets Assets	17494000	usd
CY2021Q4	us-gaap	Assets Assets	21840000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	372000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	242000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1552000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1150000	usd
CY2022Q2	us-gaap	Debt Current DebtCurrent	6000	usd
CY2021Q4	us-gaap	Debt Current DebtCurrent	509000	usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	142000	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	198000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	347000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	705000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	500000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2977000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2748000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	393000	usd
CY2022Q2	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	107000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1968000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1898000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	5445000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4646000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24719574	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24719574	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24710574	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24710574	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	247000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	247000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	267576000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	267364000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-255774000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-250417000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	12049000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	17194000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17494000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21840000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	240000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	101000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	370000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	202000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	66000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	73000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	146000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	134000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	174000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	28000	usd
	us-gaap	Gross Profit GrossProfit	224000	usd
	us-gaap	Gross Profit GrossProfit	68000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1476000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1204000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3128000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2799000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	993000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	858000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1849000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1858000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	338000	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	329000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	732000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	615000	usd
CY2022Q2	SINT	Grant Expenses GrantExpenses	150000	usd
	SINT	Grant Expenses GrantExpenses	176000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2957000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2391000	usd
	us-gaap	Operating Expenses OperatingExpenses	5885000	usd
	us-gaap	Operating Expenses OperatingExpenses	5272000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2783000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2363000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5661000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5204000	usd
CY2021Q2	us-gaap	Interest Expense Other InterestExpenseOther	1000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	8000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	1000	usd
CY2022Q2	us-gaap	Interest Income Other InterestIncomeOther	2000	usd
CY2021Q2	us-gaap	Interest Income Other InterestIncomeOther	49000	usd
	us-gaap	Interest Income Other InterestIncomeOther	3000	usd
	us-gaap	Interest Income Other InterestIncomeOther	96000	usd
CY2022Q2	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1000	usd
CY2022Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	108000	usd
CY2021Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-14000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	148000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-256000	usd
	SINT	Forgiveness Of Paycheck Protection Programe Loans ForgivenessOfPaycheckProtectionProgrameLoans	-391000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	162000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	130000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	162000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	142000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	271000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	164000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	304000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	372000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2512000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2199000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5357000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4832000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2512000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2199000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5357000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4832000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24716558	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24687916	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24714403	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24678084	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25078721	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24687916	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25080590	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24678084	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	25804000	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	36000	usd
CY2021Q1	SINT	Stock Issued During Period Value Extinguishment Of Derivative Liability Upon Exercise Of Warrant StockIssuedDuringPeriodValueExtinguishmentOfDerivativeLiabilityUponExerciseOfWarrant	195000	usd
CY2021Q1	SINT	Stock Issued During Period Value Issuance Of Common Stock Upon Exercise Of Warrants For Cash StockIssuedDuringPeriodValueIssuanceOfCommonStockUponExerciseOfWarrantsForCash	196000	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-2633000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	23598000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	80000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2199000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	21479000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	17194000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	102000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2845000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	14451000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	88000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	22000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2512000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	12049000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5357000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4832000	usd
	us-gaap	Depreciation Depreciation	137000	usd
	us-gaap	Depreciation Depreciation	70000	usd
	SINT	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	262000	usd
	SINT	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	215000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2000	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	88000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	190000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	116000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	148000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-256000	usd
	SINT	Forgivenessof Paycheck Protection Programe Loan ForgivenessofPaycheckProtectionProgrameLoan	-391000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	144000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-27000	usd
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	12000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	498000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	408000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	178000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	267000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	84000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	318000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-245000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-198000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5722000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5339000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	598000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	626000	usd
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	1944000	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	303000	usd
	SINT	Proceeds From Sale Of Property And Equipment ProceedsFromSaleOfPropertyAndEquipment	144000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-295000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1462000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	196000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	510000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	509000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	5000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-509000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	701000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6526000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3176000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14273000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25351000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7747000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22175000	usd
	SINT	Extinguishment Of Derivative Liabilities Through Exercise Of Warrants ExtinguishmentOfDerivativeLiabilitiesThroughExerciseOfWarrants	195000	usd
	SINT	Acquisition Of Subsidiary Through Assumption Of Debt AcquisitionOfSubsidiaryThroughAssumptionOfDebt	22000	usd
	SINT	Reduction Of Debt Through Increase In Accrued Liabilities ReductionOfDebtThroughIncreaseInAccruedLiabilities	100000	usd
	us-gaap	Interest Paid Net InterestPaidNet	21000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zh2wX3tBxkl6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zlhjSAD2qbb4">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the period. Actual results could differ from those estimates. As of June 30, 2022, the most significant estimate relates to derivative liabilities relating to common stock warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Net Income Loss NetIncomeLoss	-5400000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4800000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5700000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5300000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-255800000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-250400000	usd
CY2022Q2	us-gaap	Share Price SharePrice	1.00
	us-gaap	Net Income Loss NetIncomeLoss	-5357000	usd
	SINT	Net Income Effect Of Dilutive Warrant Securities NetIncomeEffectOfDilutiveWarrantSecurities	-148000	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-5505000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5357000	usd
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-148000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-5505000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24714403	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	366188	shares
CY2021Q4	us-gaap	Other Income OtherIncome	500000	usd
CY2021	us-gaap	Other Income OtherIncome	500000	usd
CY2021Q4	SINT	Reduction Of Stockholders Equity ReductionOfStockholdersEquity	500000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2400000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1800000	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2512000	usd
CY2022Q2	SINT	Net Income Effect Of Dilutive Warrant Securities NetIncomeEffectOfDilutiveWarrantSecurities	-108000	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-2620000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2512000	usd
CY2022Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-108000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2620000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24716558	shares
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	362163	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25078721	shares
CY2022Q2	SINT	Basic Net Income Loss Per Share BasicNetIncomeLossPerShare	-0.10
CY2022Q2	SINT	Earnings Per Share Diluted Net Income Loss EarningsPerShareDilutedNetIncomeLoss	-0.10
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25080590	shares
	SINT	Basic Net Income Loss Per Share BasicNetIncomeLossPerShare	-0.22
	SINT	Earnings Per Share Diluted Net Income Loss EarningsPerShareDilutedNetIncomeLoss	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-2199000	usd
CY2021Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-2199000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2199000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2199000	usd
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24687916	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24687916	shares
CY2021Q2	SINT	Basic Net Income Loss Per Share BasicNetIncomeLossPerShare	-0.09
CY2021Q2	SINT	Earnings Per Share Diluted Net Income Loss EarningsPerShareDilutedNetIncomeLoss	-0.09
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Net Income Loss NetIncomeLoss	-4832000	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-4832000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4832000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4832000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24678084	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24678084	shares
	SINT	Basic Net Income Loss Per Share BasicNetIncomeLossPerShare	-0.20
	SINT	Earnings Per Share Diluted Net Income Loss EarningsPerShareDilutedNetIncomeLoss	-0.20
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	551000	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	411000	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	126000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	134000	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	98000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	52000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	775000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	597000	usd
CY2022Q2	us-gaap	Inventory Gross InventoryGross	300000	usd
CY2022Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	400000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	300000	usd
CY2021Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	300000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	743000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	724000	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	290000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	519000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	426000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1552000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1150000	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	743089000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	833892	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.91
	SINT	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P8Y8M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	87553000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	357000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.45
	SINT	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	3	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	139237.86
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1190889	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.38
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M6D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	462229	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.22
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y1M6D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1117329	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.47
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y7M6D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	465393	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.53
	SINT	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P9Y3M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	368500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.93
	SINT	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedToVestOutstandingWeightedAverageRemainingContractualTerm1	P10Y
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	833893	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.98
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y2M12D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	743089000	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	376	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6977.42
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M18D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	833893	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.98
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9Y2M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0170	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	1.311	pure
CY2018Q4	us-gaap	Long Term Accounts Notes And Loans Receivable Net Noncurrent LongTermAccountsNotesAndLoansReceivableNetNoncurrent	6000000.0	usd
CY2018Q4	us-gaap	Debt Instrument Term DebtInstrumentTerm	P36M
CY2018Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2021-10-01
CY2018Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10	pure
	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	the Company leases 29,534
CY2022Q2	us-gaap	Area Of Land AreaOfLand	29534	sqft
	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	This lease expires at the end of 2024. The lease has two five-year extension options.
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2600000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2700000	usd
	SINT	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	300000	usd
	SINT	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	200000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	424000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	871000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	897000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	161000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	127000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	669000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3149000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	476000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2673000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	705000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1968000	usd

Files In Submission

Name	View Source	Status
0001493152-22-022235-index-headers.html	Edgar Link	pending
0001493152-22-022235-index.html	Edgar Link	pending
0001493152-22-022235.txt	Edgar Link	pending
0001493152-22-022235-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sint-20220630.xsd	Edgar Link	pending
sint-20220630_cal.xml	Edgar Link	unprocessable
sint-20220630_lab.xml	Edgar Link	unprocessable
sint-20220630_def.xml	Edgar Link	unprocessable
sint-20220630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SINT
Sintx Technologies, Inc. Stock $sint

2022 Q3 Form 10-Q Financial Statement

#000149315222022235 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SINT Sintx Technologies, Inc. Stock $sint

2022 Q3 Form 10-Q Financial Statement

#000149315222022235 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SINT
Sintx Technologies, Inc. Stock $sint